A Study to Evaluate Safety and Tolerability of QLS-101 in NTG

NCT04857827 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Normal Tension Glaucoma (NTG)

Interventions

DRUG: QLS-101
DRUG: Timolol maleate PF 0.5% ophthalmic solution

Sponsor

Qlaris Bio, Inc.